Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28545684 | 0.75 | TSHR (0.47) | MAPK1ALDH1A1TSHR | |
| SCHEMBL28927171 | 0.75 | MAPK1 (0.36) | MAPK1 | |
| Methylene Chloride SCHEMBL58997 | 0.74 | MAPK1 (0.47) | MAPK1ALDH1A1TSHR | |
| Ethyl Chloride SCHEMBL10588167 | 0.72 | MAPK1 (0.44) | MAPK1ALDH1A1TSHR | |
| SCHEMBL11377598 | 0.72 | MAPK1 (0.30) | MAPK1 | |
| Methylene Chloride SCHEMBL7521557 | 0.69 | MAPK1 (0.42) | MAPK1ALDH1A1TSHR | |
| SCHEMBL6382034 | 0.69 | TSHR (0.35) | TSHR | |
| SCHEMBL17239177 | 0.69 | — | — | |
| SCHEMBL15148177 | 0.67 | ALDH1A1 (0.35) | MAPK1ALDH1A1TSHR | |
| SCHEMBL9301862 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4632110-A1 | PROCESS FOR THE HALOGENATION OF ORGANIC COMPOUNDS | ESy-Labs-GmbH (DE) | 2025-10-15 | — | — | EP | disclosed |
| EP-4632111-A2 | PROCESS FOR THE PREPARATION OF ACETALS OF ALPHA-CHLORO- OR ALPHA-BROMO-ALDEHYDES | ESy-Labs-GmbH (DE) | 2025-10-15 | — | — | EP | disclosed |
| US-7728152-B2 | Process for producing 2-benzoyloxyacetaldehyde derivative | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-7692033-B2 | Process for producing 2-benzoyloxyacetaldehyde derivative | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-06 | — | — | US | disclosed |
| US-20090192321-A1 | PROCESS FOR PRODUCING 2-BENZOYLOXYACETALDEHYDE DERIVATIVE | NISHIKAWA KAZUYOSHI | 2009-07-30 | — | — | US | disclosed |
| US-20050234246-A1 | Process for producing 2-benzoyloxyacetaldehyde derivative | DAICEL CHEMICAL INDUSTRIES, LTD. | 2005-10-20 | — | — | US | disclosed |
| EP-0247234-B1 | PROCESS FOR THE MANUFACTURE OF ACETALS OF CHLORO- OR BROMOACETALDEHYDE | National Starch and Chemical Corporation (US) | 1990-01-17 | — | — | EP | disclosed |
| EP-0247234-A1 | Process for the manufacture of acetals of chloro- or bromoacetaldehyde | National Starch and Chemical Corporation (US) | 1987-12-02 | — | — | EP | disclosed |
| US-4642390-A | Process for the manufacture of acetals of chloroacetaldehyde | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1987-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234246-A1 | Process for producing 2-benzoyloxyacetaldehyde derivative | ALDH1A1, ALDH2, CBR1 | MAPK1 1902/4885ALDH1A1 1/4885TSHR 1824/4885 |
| US-20090192321-A1 | PROCESS FOR PRODUCING 2-BENZOYLOXYACETALDEHYDE DERIVATIVE | ALDH1A1, ALDH2, CBR1 | MAPK1 1902/4885ALDH1A1 1/4885TSHR 1824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.